386 related articles for article (PubMed ID: 10721486)
21. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
22. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
23. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
26. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
28. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.
Scholl PR; Trede N; Chatila TA; Geha RS
J Immunol; 1992 Apr; 148(7):2237-41. PubMed ID: 1545128
[TBL] [Abstract][Full Text] [Related]
29. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
[TBL] [Abstract][Full Text] [Related]
30. Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA.
Griggs ND; Pontzer CH; Jarpe MA; Johnson HM
J Immunol; 1992 Apr; 148(8):2516-21. PubMed ID: 1560207
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands.
Espel E; Garcia-Sanz JA; Aubert V; Menoud V; Sperisen P; Fernández N; Spertini F
Eur J Immunol; 1996 Oct; 26(10):2417-24. PubMed ID: 8898955
[TBL] [Abstract][Full Text] [Related]
32. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcal toxins bind to different sites on HLA-DR.
Chintagumpala MM; Mollick JA; Rich RR
J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking of superantigens with class II major histocompatibility complex proteins.
Olson MA; Cuff L
J Mol Recognit; 1997; 10(6):277-89. PubMed ID: 9770652
[TBL] [Abstract][Full Text] [Related]
35. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
36. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
Kum WW; Cameron SB; Hung RW; Kalyan S; Chow AW
Infect Immun; 2001 Dec; 69(12):7544-9. PubMed ID: 11705931
[TBL] [Abstract][Full Text] [Related]
37. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
Nilsson H; Björk P; Dohlsten M; Antonsson P
J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
[TBL] [Abstract][Full Text] [Related]
39. Agonist properties of a microbial superantigen peptide.
Pontzer CH; Griggs ND; Johnson HM
Biochem Biophys Res Commun; 1993 Jun; 193(3):1191-7. PubMed ID: 8323541
[TBL] [Abstract][Full Text] [Related]
40. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
